The impact of level of documentation on the accessibility and affordability of new drugs in Norway

Introduction: Over the preceding decade, an increasing number of drugs have been approved by the European Medicines Agency (EMA) with limited knowledge of their relative efficacy. This is due to the utilization of non-randomized, single-arm studies, surrogate endpoints, and shorter follow-up time. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Gro Live Fagereng (Author), Anne Marit Morvik (Author), Sara Reinvik Ulimoen (Author), Anne Marthe Ringerud (Author), Iselin Dahlen Syversen (Author), Erik Sagdahl (Author)
Format: Book
Published: Frontiers Media S.A., 2024-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!